Leveraging human genetics to develop future therapeutic strategies in rheumatoid arthritis

Rheum Dis Clin North Am. 2010 May;36(2):259-70. doi: 10.1016/j.rdc.2010.03.002.

Abstract

The purpose of this article is to place these genetic discoveries in the context of current and future therapeutic strategies for patients with RA. More specifically, this article focuses on (1) a brief overview of genetic studies, (2) human genetics as an approach to identify the Achilles heel of disease pathways, (3) humans as the model organism for functional studies of human mutations, (4) pharmacogenetic studies to gain insight into the mechanism of action of drugs, and (5) next-generation patient registries to enable large-scale genotype-phenotype studies.

Publication types

  • Review

MeSH terms

  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / epidemiology
  • Arthritis, Rheumatoid / genetics*
  • Drug Discovery / methods*
  • Genotype
  • Humans
  • Pharmacogenetics / methods*
  • Phenotype
  • Registries
  • Risk Factors

Substances

  • Antirheumatic Agents